0001209191-17-027327.txt : 20170418 0001209191-17-027327.hdr.sgml : 20170418 20170418171927 ACCESSION NUMBER: 0001209191-17-027327 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170418 DATE AS OF CHANGE: 20170418 EFFECTIVENESS DATE: 20170418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gila Therapeutics, Inc. CENTRAL INDEX KEY: 0001673503 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-262438 FILM NUMBER: 17767620 BUSINESS ADDRESS: STREET 1: 1712 HUMBOLT AVENUE SOUTH CITY: MINNEAPOLIS STATE: MN ZIP: 55403 BUSINESS PHONE: 612-805-9054 MAIL ADDRESS: STREET 1: 1712 HUMBOLT AVENUE SOUTH CITY: MINNEAPOLIS STATE: MN ZIP: 55403 D/A 1 primary_doc.xml X0707 D/A LIVE 0001673503 Gila Therapeutics, Inc. 1712 Humbolt Avenue South Minneapolis MN MINNESOTA 55403 612-805-9054 DELAWARE None None Corporation true 2014 Thomas J. Vasicek 1712 Humbolt Avenue South Minneapolis MN MINNESOTA 55403 Executive Officer Director Promoter Andres Acosta 1712 Humbolt Avenue South Minneapolis MN MINNESOTA 55403 Promoter Sergei Zolutukhin 1712 Humbolt Avenue South Minneapolis MN MINNESOTA 55403 Promoter Jon Freeman 1712 Humbolt Avenue South Minneapolis MN MINNESOTA 55403 Executive Officer Christopher DeSouza 1712 Humbolt Avenue South Minneapolis MN MINNESOTA 55403 Director Richard Horan 1712 Humbolt Avenue South Minneapolis MN MINNESOTA 55403 Director Biotechnology Decline to Disclose 06b true 0001209191-16-116749 2016-04-15 true true false 0 4000000 3344885 655115 false 33 0 0 0 false Gila Therapeutics, Inc. /s/ Thomas J. Vasicek Thomas J. Vasicek Chief Executive Officer 2017-04-18